ALK-Abello A-S

ALK-Abelló A/S, generally known as ALK, is a pharmaceutical business established in Denmark that specializes in the research and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergies. It is one of the world's largest manufacturers of allergy immunotherapy treatments (commonly known as 'allergy vaccinations,' accounting for 81% of its revenue.

Allergies affect around 500 million people worldwide. Many of them grieve in silence because the road ahead is incomprehensible. ALK hopes to make allergy management unexpectedly simple by gathering information and the latest and most reliable remedies in one location. Nobody knows allergy like them, and they constantly apply scientific knowledge and skills to assist individuals take control of their allergy and their lives. ALK wants to make a difference by providing solutions for everyone affected by allergies - through a complete range of products, services, and resources that provide a quick path to a more balanced life.

ALK has continually devised and achieved key advancements in allergy treatment since 1923. ALK has invested significantly in the research and development of innovative, evidence-based allergy immunotherapy medicines in recent years, in collaboration with global partners.

Founded: 1923

Headquarters: Hørsholm, Denmark

Website: https://www.alk.net/